Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The risk of late effects following pediatric and adult radiotherapy regimens in Hodgkin lymphoma

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comparative analysis of postoperative adjuvant radiotherapy in glioblastoma multiforme

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  1. Genomforskningsprojekt påviser TP53-mutation hos en pige med rabdomyosarkom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinicopathologic characteristics of Burkitt lymphoma of the head and neck in a non-endemic region-a Danish nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: Adolescent young adults (AYA) with Hodgkin lymphoma (HL) are treated according to either pediatric or adult protocols, however, the best strategy has yet to be established. We describe the AYA patients referred for radiotherapy and quantify the risk of radiation-induced late effects and the corresponding life years lost (LYL) following pediatric and adult regimens.

METHODS: Patients ≤24 years irradiated for HL were included. For each patient, organs at risk (OARs) were contoured and dosimetric parameters were extracted. Estimated excess hazard ratios of radiation-induced late effects were calculated from dose-response models and LYL attributable to various late effects were estimated.

RESULTS: In total, 77 patients were analyzed (pediatric regimen: 15; adult regimen: 62). Age, clinical stage, and the number of patients enrolled in protocols were significantly different between the groups. Pediatric patients had more advanced disease, which resulted in larger target volumes and higher doses to most OARs, despite a lower prescribed dose compared to adult regimens. LYL estimates were all higher with the pediatric regimens. Total LYL with pediatric and adult treatment regimens were 3.2 years and 2.3 years, respectively. Due to the clinical stage variation and heterogeneity in disease location, a direct comparison of the estimated risks of late effects was only exploratory.

CONCLUSION: Pediatric regimens selected patients with more advanced disease to radiotherapy resulting in larger target volumes and higher doses to the OARs. Target volume rather than prescribed dose impacted OAR exposure. Consequently, the estimated risk of radiation-induced late effects and corresponding LYL was increased when compared to adult regimens.

Original languageEnglish
JournalStrahlentherapie und Onkologie
Volume197
Issue number8
Pages (from-to)711-721
Number of pages11
ISSN0179-7158
DOIs
Publication statusPublished - Aug 2021

    Research areas

  • Adolescent young adults, Life years lost, Organs at risk, Pediatrics, Radiation-induced late effects

ID: 61780999